219 related articles for article (PubMed ID: 20007298)
1. Transcription coactivator PBP/MED1-deficient hepatocytes are not susceptible to diethylnitrosamine-induced hepatocarcinogenesis in the mouse.
Matsumoto K; Huang J; Viswakarma N; Bai L; Jia Y; Zhu YT; Yang G; Borensztajn J; Rao MS; Zhu YJ; Reddy JK
Carcinogenesis; 2010 Feb; 31(2):318-25. PubMed ID: 20007298
[TBL] [Abstract][Full Text] [Related]
2. Critical role for transcription coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein/TRAP220 in liver regeneration and PPARalpha ligand-induced liver tumor development.
Matsumoto K; Yu S; Jia Y; Ahmed MR; Viswakarma N; Sarkar J; Kashireddy PV; Rao MS; Karpus W; Gonzalez FJ; Reddy JK
J Biol Chem; 2007 Jun; 282(23):17053-60. PubMed ID: 17438330
[TBL] [Abstract][Full Text] [Related]
3. Transcription coactivator mediator subunit MED1 is required for the development of fatty liver in the mouse.
Bai L; Jia Y; Viswakarma N; Huang J; Vluggens A; Wolins NE; Jafari N; Rao MS; Borensztajn J; Yang G; Reddy JK
Hepatology; 2011 Apr; 53(4):1164-74. PubMed ID: 21480322
[TBL] [Abstract][Full Text] [Related]
4. [Hyperlipidemia in hepatic MED1 deficient mice in response to fasting].
Bai L; Fu T; Jia Y; Borensztajn J; Reddy JK; Yang G
Sheng Wu Gong Cheng Xue Bao; 2011 Oct; 27(10):1490-8. PubMed ID: 22260066
[TBL] [Abstract][Full Text] [Related]
5. Role of Myc in hepatocellular proliferation and hepatocarcinogenesis.
Qu A; Jiang C; Cai Y; Kim JH; Tanaka N; Ward JM; Shah YM; Gonzalez FJ
J Hepatol; 2014 Feb; 60(2):331-8. PubMed ID: 24096051
[TBL] [Abstract][Full Text] [Related]
6. Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity.
Jia Y; Guo GL; Surapureddi S; Sarkar J; Qi C; Guo D; Xia J; Kashireddi P; Yu S; Cho YW; Rao MS; Kemper B; Ge K; Gonzalez FJ; Reddy JK
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12531-6. PubMed ID: 16109766
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP) but not PPAR-interacting protein (PRIP) is required for nuclear translocation of constitutive androstane receptor in mouse liver.
Guo D; Sarkar J; Ahmed MR; Viswakarma N; Jia Y; Yu S; Sambasiva Rao M; Reddy JK
Biochem Biophys Res Commun; 2006 Aug; 347(2):485-95. PubMed ID: 16828057
[TBL] [Abstract][Full Text] [Related]
8. Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver.
Jia Y; Qi C; Kashireddi P; Surapureddi S; Zhu YJ; Rao MS; Le Roith D; Chambon P; Gonzalez FJ; Reddy JK
J Biol Chem; 2004 Jun; 279(23):24427-34. PubMed ID: 15150259
[TBL] [Abstract][Full Text] [Related]
9. β-Catenin loss in hepatocytes promotes hepatocellular cancer after diethylnitrosamine and phenobarbital administration to mice.
Awuah PK; Rhieu BH; Singh S; Misse A; Monga SP
PLoS One; 2012; 7(6):e39771. PubMed ID: 22761897
[TBL] [Abstract][Full Text] [Related]
10. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.
Tamano S; Merlino GT; Ward JM
Carcinogenesis; 1994 Sep; 15(9):1791-8. PubMed ID: 7923571
[TBL] [Abstract][Full Text] [Related]
11. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
[TBL] [Abstract][Full Text] [Related]
12. Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice.
Braeuning A; Gavrilov A; Geissler M; Wenz C; Colnot S; Templin MF; Metzger U; Römer M; Zell A; Schwarz M
Arch Toxicol; 2016 Jun; 90(6):1481-94. PubMed ID: 26838046
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in mice administered the peroxisome proliferator Wy-14,643.
Glauert HP; Eyigor A; Tharappel JC; Cooper S; Lee EY; Spear BT
Toxicol Sci; 2006 Apr; 90(2):331-6. PubMed ID: 16434500
[TBL] [Abstract][Full Text] [Related]
14. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital.
Loeppen S; Schneider D; Gaunitz F; Gebhardt R; Kurek R; Buchmann A; Schwarz M
Cancer Res; 2002 Oct; 62(20):5685-8. PubMed ID: 12384525
[TBL] [Abstract][Full Text] [Related]
16. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice.
Ward JM; Rice JM; Creasia D; Lynch P; Riggs C
Carcinogenesis; 1983 Aug; 4(8):1021-9. PubMed ID: 6872148
[TBL] [Abstract][Full Text] [Related]
17. 1alpha, 25-dihydroxyvitamin D3 prevents DNA damage and restores antioxidant enzymes in rat hepatocarcinogenesis induced by diethylnitrosamine and promoted by phenobarbital.
Banakar MC; Paramasivan SK; Chattopadhyay MB; Datta S; Chakraborty P; Chatterjee M; Kannan K; Thygarajan E
World J Gastroenterol; 2004 May; 10(9):1268-75. PubMed ID: 15112340
[TBL] [Abstract][Full Text] [Related]
18. Med1 subunit of the mediator complex in nuclear receptor-regulated energy metabolism, liver regeneration, and hepatocarcinogenesis.
Jia Y; Viswakarma N; Reddy JK
Gene Expr; 2014; 16(2):63-75. PubMed ID: 24801167
[TBL] [Abstract][Full Text] [Related]
19. Cyclin E facilitates dysplastic hepatocytes to bypass G1/S checkpoint in hepatocarcinogenesis.
Pok S; Wen V; Shackel N; Alsop A; Pyakurel P; Fahrer A; Farrell GC; Teoh NC
J Gastroenterol Hepatol; 2013 Sep; 28(9):1545-54. PubMed ID: 23574010
[TBL] [Abstract][Full Text] [Related]
20. STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice.
Kaltenecker D; Themanns M; Mueller KM; Spirk K; Golob-Schwarzl N; Friedbichler K; Kenner L; Haybaeck J; Moriggl R
Cytokine; 2019 Dec; 124():154573. PubMed ID: 30377054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
